secwatch / observer
8-K filed December 6, 2023, 6:59 PM ET ticker BNBX CIK 0000744452
regulatory confidence high sentiment negative materiality 0.70

BNB PLUS CORP. (BNBX): Nasdaq/NYSE listing notice — APDN receives Nasdaq bid price non-compliance notice; cure period ends May 29, 2024

BNB PLUS CORP.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

BNB PLUS CORP. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
minimum bid price
Rules
5550(a)(2), 5810(c)(3)(A)
Exact text from the filing
December 1, 2023, Applied DNA Sciences, Inc. (the “Company”) received written notice (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement e
View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

BNB PLUS CORP. filing history →

Source: SEC EDGAR
accession 0001104659-23-123962
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.